CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Zhuzhou Qianjin Pharmaceutical Co., Ltd. Company Snapshot
Zhuzhou Qianjin Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhuzhou Qianjin Pharmaceutical Co., Ltd. with three other companies in this sector in CHINA : Heilongjiang ZBD Pharmaceutical Co Ltd (2019 sales of 3.29 billion Chinese Renmimbi [US$461.34 million] of which 62% was Pharmaceutical Industry), Guizhou Yibai Pharmaceutical Co., Ltd. (3.36 billion Chinese Renmimbi [US$471.05 million] of which 83% was Medical Industry), and Hengkang Medical Group Co Ltd (3.68 billion Chinese Renmimbi [US$516.30 million] of which 87% was Medical service).

Sales Analysis. During the year ended December of 2019, sales at Zhuzhou Qianjin Pharmaceutical Co., Ltd. were 3.52 billion Chinese Renmimbi (US$493.98 million). This is an increase of 5.9% versus 2018, when the company's sales were 3.33 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Zhuzhou Qianjin Pharmaceutical Co., Ltd. (and since 2014, sales have increased a total of 61%). Sales of Medicine Retail Sales and Wholesales saw an increase that was more than double the company's growth rate: sales were up 13.0% in 2019, from 1.52 billion Chinese Renmimbi to 1.72 billion Chinese Renmimbi. Not all segments of Zhuzhou Qianjin Pharmaceutical Co., Ltd. experienced an increase in sales in 2019: sales of Other fell 7.0% to 269.12 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
  Stock Performance Chart for Zhuzhou Qianjin Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 9.01
(Figures in Chinese Renmimbi)
1 Week 1.0%   13 Weeks -0.8%  
4 Weeks -4.4%   52 Weeks -5.5%  
 
Zhuzhou Qianjin Pharmaceutical Co., Ltd. Key Data:
  Ticker: 600479 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 3,524,656,944
(Year Ending Jan 2020).
Employees: 5,028
  Currency: Chinese Renmimbi Market Cap: 3,770,749,124
  Fiscal Yr Ends: December Shares Outstanding: 418,507,117
  Share Type: A Gu Closely Held Shares: 150,566,802
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.